Novocure (NVCR) Tops Q3 EPS by 9c

Novocure (NASDAQ: NVCR) reported Q3 EPS of ($0.33), $0.09 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $167 million versus the consensus estimate of $158.54 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30
• Jefferies cuts China online beauty outlook after July slowdown